Schalken JA - Search Results

1

Polymorphisms in the E-cadherin (CDH1) gene promoter and the risk of bladder cancer.

Kiemeney LA, van Houwelingen KP, Bogaerts M, Witjes JA, Swinkels DW, den Heijer M, Franke B, Schalken JA, Verhaegh GW. Kiemeney LA, et al. Among authors: schalken ja. Eur J Cancer. 2006 Dec;42(18):3219-27. doi: 10.1016/j.ejca.2006.05.033. Epub 2006 Aug 28. Eur J Cancer. 2006. PMID: 16934975

2

Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer.

Umbas R, Schalken JA, Aalders TW, Carter BS, Karthaus HF, Schaafsma HE, Debruyne FM, Isaacs WB. Umbas R, et al. Among authors: schalken ja. Cancer Res. 1992 Sep 15;52(18):5104-9. Cancer Res. 1992. PMID: 1516067

3

Differential expression of vimentin in rat prostatic tumors.

Bussemakers MJ, Verhaegh GW, van Bokhoven A, Debruyne FM, Schalken JA. Bussemakers MJ, et al. Among authors: schalken ja. Biochem Biophys Res Commun. 1992 Feb 14;182(3):1254-9. doi: 10.1016/0006-291x(92)91866-o. Biochem Biophys Res Commun. 1992. PMID: 1540169

4

Decreased expression of E-cadherin in the progression of rat prostatic cancer.

Bussemakers MJ, van Moorselaar RJ, Giroldi LA, Ichikawa T, Isaacs JT, Takeichi M, Debruyne FM, Schalken JA. Bussemakers MJ, et al. Among authors: schalken ja. Cancer Res. 1992 May 15;52(10):2916-22. Cancer Res. 1992. PMID: 1581909

5

Expression of markers for transitional cell carcinoma in normal bladder mucosa of patients with bladder cancer.

Witjes JA, Umbas R, Debruyne FM, Schalken JA. Witjes JA, et al. Among authors: schalken ja. J Urol. 1995 Dec;154(6):2185-9. J Urol. 1995. PMID: 7500486

6

Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer.

Umbas R, Isaacs WB, Bringuier PP, Schaafsma HE, Karthaus HF, Oosterhof GO, Debruyne FM, Schalken JA. Umbas R, et al. Among authors: schalken ja. Cancer Res. 1994 Jul 15;54(14):3929-33. Cancer Res. 1994. PMID: 7518346

7

Defective E-cadherin function in urological cancers: clinical implications and molecular mechanisms.

Giroldi LA, Bringuier PP, Schalken JA. Giroldi LA, et al. Among authors: schalken ja. Invasion Metastasis. 1994-1995;14(1-6):71-81. Invasion Metastasis. 1994. PMID: 7657535 Review.

8

Molecular prognostic factors in bladder cancer.

Vet JA, Debruyne FM, Schalken JA. Vet JA, et al. Among authors: schalken ja. World J Urol. 1994;12(2):84-8. doi: 10.1007/BF00184242. World J Urol. 1994. PMID: 7916239 Review.

9

p53 mutations have no additional prognostic value over stage in bladder cancer.

Vet JA, Bringuier PP, Poddighe PJ, Karthaus HF, Debruyne FM, Schalken JA. Vet JA, et al. Among authors: schalken ja. Br J Cancer. 1994 Sep;70(3):496-500. doi: 10.1038/bjc.1994.334. Br J Cancer. 1994. PMID: 8080737 Free PMC article.

10

Transcriptional regulation of the human E-cadherin gene in human prostate cancer cell lines: characterization of the human E-cadherin gene promoter.

Bussemakers MJ, Giroldi LA, van Bokhoven A, Schalken JA. Bussemakers MJ, et al. Among authors: schalken ja. Biochem Biophys Res Commun. 1994 Sep 15;203(2):1284-90. doi: 10.1006/bbrc.1994.2321. Biochem Biophys Res Commun. 1994. PMID: 8093045

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

423 results

Search Page

Filters